Skip to content
MedGenome US is now rebranded as Signios Bio – same team, renewed identity.
  • Login
  • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Academics and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Diagnostics Laboratories
    • Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Multiomics – Academics and Research Institutes
    • Multiomics – Pharmaceutical & Biotechnology Companies
    • Multiomics – Clinical & Diagnostics Laboratories
    • Multiomics – Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
  • Company
    • About
    • News & Events
    • Careers
    • Contact
  • Login

2021

Drug-resistant ‘Non-Lesional’ Visual Sensitive Epilepsies of Childhood – Electroclinical Phenotype-Genotype Associations

December 25, 2021

Novel Consensus Splice Site Pathogenic Variation in THOC2 Gene Leads to Recurrent Arthrogryposis Multiplex Congenita Phenotype: A Case Report

November 28, 2021

Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort

November 26, 2021

Growth and neurodevelopmental disorder with arthrogryposis, microcephaly and structural brain anomalies caused by Bi-allelic partial deletion of SMPD4 gene

October 8, 2021

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center

October 4, 2021

Initial experience and results of a cardiogenetic clinic in a tertiary cardiac care center in India

August 26, 2021

Spinocerebellar Ataxia 28 Presenting as Predominantly Generalized Dystonia

August 5, 2021

Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndrome

August 3, 2021

Retinoblastoma genetics screening and clinical management

July 29, 2021

Nemaline Rod/Cap Myopathy Due to Novel Homozygous MYPN Mutations: The First Report from South Asia and Comprehensive Literature Review

July 29, 2021
Post pagination
1 2 3 Next →
Locations:
US:

Signios Biosciences
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

India:
MedGenome Labs Ltd.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100
  • Sequencing Services
  • Multiomics Solutions
  • Bioinformatics Solutions
  • Resources
  • Company
  • Login
  • Contact

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.

 

© 2026 SIGNIOSBIO. All Rights Reserved.